Competition between recipient and donor cells after bone marrow transplantation for chronic myeloid leukaemia
- 1 August 1988
- journal article
- research article
- Published by Wiley in British Journal of Haematology
- Vol. 69 (4) , 471-475
- https://doi.org/10.1111/j.1365-2141.1988.tb02401.x
Abstract
The cytogenetic and clinical course of three patients allografted for Ph positive chronic myleoid leukaemia are reported. All patients had a peculiar pattern of relapse. Two out of three patients had donor marrow graft pretreated with monoclonal antibody for graft versus host prevention. The cytogenetic relapse was invariably associated with major morphological changes in the marrow indicating that these were also haematological relapses. However, no changes in the peripheral blood count were observed. When relapse occurred in these patients. Ph positive marrow metaphases and host red blood cells ranged from 75% to 100% of the total cell population: thereafter they spontaneously reverted to complete chimaerism. Therefore the presence of leukaemic cells even in considerable amount was not sufficient, per se, to prevail over normal marrow. In addition these observations indicate that relapse was not associated with elimination of the graft: while haemopoiesis was entirely of recipient origin the donor normal stem cells were present and vital although functionally silent. These data suggest that, although TBI remains the more effective tool for eradicating the majority of leukaemic cells, haemopoietic competition between host and donor marrow may have a major impact on leukaemic relapse.This publication has 14 references indexed in Scilit:
- Cytogenetic follow-up studies of recipients of T-cell depleted allogeneic bone marrowBritish Journal of Haematology, 1987
- GRAFT REJECTION AND GRAFT-VERSUS-HOST DISEASE: MIRROR IMAGESThe Lancet, 1986
- Competitive survival/proliferation of normal and Ph1‐positive haemopoietic cellsBritish Journal of Haematology, 1986
- Bone Marrow Transplantation for Patients with Chronic Myeloid LeukemiaNew England Journal of Medicine, 1986
- Unusual Ph translocations in CML: Four new casesCancer Genetics and Cytogenetics, 1985
- Intravenous Monoclonal Antibody (BT 5/9) for the Treatment of Acute Graft-versus-Host DiseaseActa Haematologica, 1985
- HOW DOES BONE-MARROW TRANSPLANTATION CURE LEUKAEMIA?The Lancet, 1984
- Long-Term Marrow Culture Reveals Chromosomally Normal Hematopoietic Progenitor Cells in Patients with Philadelphia Chromosome-Positive Chronic Myelogenous LeukemiaNew England Journal of Medicine, 1983
- Chromosome abnormalities in cancerCancer Genetics and Cytogenetics, 1980
- Bone-Marrow TransplantationNew England Journal of Medicine, 1975